Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group
Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773)
12/2005
12/20/2005CA2338206C High affinity ligands for nociceptin receptor orl-1
12/20/2005CA2176962C N-substituted azabicycloheptane derivatives, their preparation and use
12/20/2005CA2174127C Phenylsulfonyl ureas, processes for their preparation, and their use as herbicides and plant growth regulators
12/20/2005CA2114007C Substituted beta-lactam compounds useful as hypocholesterolemic agents and processes for the preparation thereof
12/15/2005WO2005119315A2 Non-linear optically active molecules, their synthesis, and use
12/15/2005WO2005118579A2 Thiazole derivatives as chemokine receptor antagonists
12/15/2005WO2005118578A1 Mercaptoimidazoles as ccr2 receptor antagonists
12/15/2005WO2005118574A1 Mercaptoimidazoles as ccr2 receptor antagonists
12/15/2005WO2005118572A1 Quinazoline derivatives as erbb receptor tyrosine kinases
12/15/2005WO2005118558A2 Pyrimidine compounds and use thereof
12/15/2005WO2005118557A2 Heterocyclic compounds and their use as aldosterone synthase inhibitors
12/15/2005WO2005118535A1 Substituted pyrrolidine-2-ones
12/15/2005WO2005117867A2 Monocyclic heterocycles as kinase inhibitors
12/15/2005WO2005105065A3 Thiazole-based nitric oxide donors for treating inflammatory bowel diseases
12/15/2005WO2005097763A3 1,3,4-oxadiazol-2-ones as ppar delta
12/15/2005WO2005097762A3 1,3,4-oxadiazol-2-ones as ppar delta modulators
12/15/2005WO2005060665A3 3-cycloalkylaminopyrrolidine derivatives as modulators of chemokine receptors
12/15/2005WO2005060571A3 Antiprotozoal imidazopyridine compounds
12/15/2005WO2004098590A8 4-bromo-5- (2-chloro-benzoylamino)-1h-pyrazole-3-carboxylic acid (1-(aminocarbonyl) eth-1-yl) amide derivatives and related compounds as bradykinin b1 receptor antagonists for the treatment of inflammatory diseases
12/15/2005WO2004014313A3 Combination pharmaceutical agents as inhibitors of hcv replication
12/15/2005US20050277686 Benzimidazole compounds for regulating IgE
12/15/2005US20050277683 Novel pyrrolidine bicyclic compounds and its derivatives, compositions and methods of use
12/15/2005US20050277679 Antidiabetic agents; dietetics; hypoglycermic agents; stable, high melting crystalline material, suitable for bulk preparation and handling
12/15/2005US20050277676 M3muscarinic acetylcholine receptor antagonists
12/15/2005US20050277673 such as 4-{[4-({[(3-isopropyl-2-oxo-2,3-dihydro-1H-benzimidazol-1-yl)carbonyl]amino}methyl)piperidin-1-yl]methyl}tetrahydro-2H-pyran-4-carboxylic acid; serotonin receptor agonist; antidepressant, anxiolytic agent, analgesic, cognition activator; less toxicity, good absorption, and metabolic stability
12/15/2005US20050277671 Benzimidazolone carboxylic acid derivatives
12/15/2005US20050277670 Chemokine receptor binding compounds
12/15/2005US20050277668 viricide, antiinflammatory agent; autoimmune diseases; protective effects against infection of target cells by a human immunodeficiency virus (HIV); 6-Chloro-N-((R)-3-{4-[(4-methoxy-phenyl)-(4-methyl-pyridin-3-ylmethyl)-amino]-piperidin-1-yl}-butyl)-2,4-dimethyl-nicotinamide
12/15/2005US20050277665 e.g. 1,1,1-trifluoro-2-[4-(toluene-2-sulfonyl)phenyl]-propan-2-ol; hydroxysteroid dehydrogenases inhibitor; interconversion between cortisone and cortisol in humans; antidiabetic agent; obesity, insulin resistance, non-insulin -dependent diabetes
12/15/2005US20050277663 3-Aryl-3-hydroxy-and 3-aryl-3-oxopropionic acid esters as fungicides
12/15/2005US20050277654 4,5-Disubstituted-2-aryl pyrimidines
12/15/2005US20050277651 Reacting ziprasidone with hydrochloric acid in solvent; salt formation; drying
12/15/2005US20050277646 N-[4-({5-(4-fluorophenyl)-4-[4-(trifluoromethyl)phenyl]pyridin-2-yl}oxy)-1,3-benzothiazol-2-yl]acetamide; vanilloid (capsaicin) receptor antagonist/agonist; antiinflammatory, analgesic, antiarthritis, antirheumatic; diseases involving sensory nerve function
12/15/2005US20050277631 Vanilloid receptor ligands and their use in treatments
12/15/2005US20050277628 Substituted thiophene carboxamides
12/15/2005CA2778894A1 Compounds for measuring nitroreductase enzyme activity
12/15/2005CA2568165A1 Heterocyclic compounds and their use as aldosterone synthase inhibitors
12/15/2005CA2567832A1 Quinazoline derivatives as erbb receptor tyrosine kinases
12/15/2005CA2566187A1 Mercaptoimidazoles as ccr2 receptor antagonists
12/15/2005CA2565705A1 Non-linear optically active molecules, their synthesis, and use
12/15/2005CA2565689A1 Substituted pyrrolidine-2-ones
12/15/2005CA2565280A1 Mercaptoimidazoles as ccr2 receptor antagonists
12/15/2005CA2563831A1 Monocyclic heterocycles as kinase inhibitors
12/14/2005EP1604979A1 2-oxo-1-pyrrolidine derivative and its pharmaceutical uses
12/14/2005EP1603905A1 Vanilloid receptor ligands and their use in treatments
12/14/2005EP1603901A1 Tetrahydropyran compounds as tachykinin antagonists
12/14/2005EP1603899A1 Heterocyclic urea derivatives for the treatment of pain
12/14/2005EP1603886A1 4-substituted-5-cyano-1h-pyrimidin-6-(thi)ones as gsk-3 inhibitors
12/14/2005EP1603885A1 Fused tri and tetra-cyclic pyrazole kinase inhibitors
12/14/2005EP1603879A2 Substituted pyridine derivatives useful in the treatment of cancer and other disorders
12/14/2005EP1603572A1 Lactam-containing cyclic diamines and derivatives as factor xa inhibitors
12/14/2005EP1603570A2 Aminoheteroaryl compounds as protein kinase inhibitors
12/14/2005EP1427709B1 3-substituted-4-pyrimidone derivatives
12/14/2005EP1417189B1 Acylaminothiazole derivatives, their preparation and therapeutic use
12/14/2005EP1326858B1 Piperidine compounds as anti-allergic
12/14/2005EP1224165B1 Novel compounds
12/14/2005EP1112255B1 4,4-biarylpiperidine derivatives with opioid receptor activity
12/14/2005CN1708496A Cyclopropyl-thienyl-carboxamide as fungicides
12/14/2005CN1708482A N-sulfonyl-4-methyleneamino-3-hydroxy-2-pyridones as antimicrobials
12/14/2005CN1708481A N-alkyl-4-methyleneamino-3-hydroxy-2-pyridones as antimicrobials
12/14/2005CN1231482C Processes for the preparation of thiazolidinedione derivatives and intermediates
12/14/2005CN1231481C An improved process for the preparation of thiazolidine-2,4-dione derivatives
12/14/2005CN1231480C 1,2,3-thiadiazole carboxylic acid (thio) esters and use thereof as pest control agent or as microbicide
12/14/2005CN1231476C Substd. pyridine herbicides
12/14/2005CN1231467C High affinity ligands for nociceptin receptor ORL-1
12/14/2005CN1231466C New piperidine derivatives
12/14/2005CA2471219A1 Improved preparation of an anhydrate form of 5-[2-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]ethyl]-6-chloro-1,3-dihydro-2h-indol-2-one hydrochloride (ziprasidone hydrochloride)
12/13/2005US6974873 Preferential compound for use as diagnostic tool
12/13/2005US6974869 Piperizinones as modulators of chemokine receptor activity
12/13/2005US6974826 such as 3-(3,5,5,8,8-pentamethyl-5,6,7,8-tetrahydro-2-naphthyl)-4-methoxybenzylidene-2,4-thiazolidinedione; Hodgkin's disease
12/13/2005US6974818 1,2,5-thiadiazol-3-YL-piperazine therapeutic agents useful for treating pain
12/13/2005US6974813 For therapy of perioperative myocardial ischemic injury in mammals, including humans
12/13/2005CA2234066C Substituted imidazoles having anti-cancer and cytokine inhibitory activity
12/12/2005WO2005121110A1 Hetroaryl benzamide derivatives for use as glk activators in the treatment of diabetes
12/08/2005WO2005116653A2 Modulators of human g protein-coupled receptors for the treatment of hyperglycemia and related disorders
12/08/2005WO2005116026A1 4-hydroxy-4-methyl-piperidine-1-carboxylic acid (4-methoxy-7-morpholin-4-yl-benzothiazol-2-yl)-amide
12/08/2005WO2005116025A2 2-substituted-4-heteroaryl-pyrimidines useful for the treatment of proliferative disorders
12/08/2005WO2005116014A1 Proline derivatives and their use as dipeptidyl peptidase iv inhibitors
12/08/2005WO2005116009A1 Substituted 2-quinolyl-oxazoles useful as pde4 inhibitors
12/08/2005WO2005116003A2 Substituted oxazolobenzoisothiazole dioxide derivatives method for production and use thereof
12/08/2005WO2005116002A2 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
12/08/2005WO2005116001A1 Substituted thiazoleacetic as crth2 ligands
12/08/2005WO2005116000A1 Compounds and compositions as ppar modulators
12/08/2005WO2005115990A1 Cinnamide compound
12/08/2005WO2005115985A1 Aminopyridine derivatives as selective dopamine d3 agonists
12/08/2005WO2005115983A1 Aryl sulfonamide and sulfonyl compounds as modulators of ppar and methods of treating metabolic disorders
12/08/2005WO2005115977A1 Pyrrolidine derivatives as cb1-receptor antagonists
12/08/2005WO2005115976A1 3-amino-2-phenylpyrrolidine derivatives
12/08/2005WO2005115975A1 Arylalkylamines and process for production thereof
12/08/2005WO2005115392A2 3-(4-heteroarylcyclohexylamino) cyclopentanecarboxamides as modulators of chemokine receptors
12/08/2005WO2005115148A1 3-aryl-3-hydroxy-2-methylenepropionic acid esters as fungicides
12/08/2005WO2005080387A3 Processes for making pioglitazone and compounds of the processes
12/08/2005WO2005077926A3 Benzofuran and benzothiophene derivatives useful for the treatment of cardiovascular disease
12/08/2005WO2005075436A3 Novel inhibitors of glutaminyl cyclase
12/08/2005WO2005047526A3 Method for identifying inhibitors using a homology model of polo-like kinase 1
12/08/2005WO2004098589A8 4- bromo - 5 - (2- chloro - benzoylamino) - 1h - pyrazole - 3 - carboxylic acid amide derivatives and related compounds as bradykinin b1 receptor antagonists for the treatment of inflammatory diseases
12/08/2005WO2004058911A3 Organic electroluminescent element
12/08/2005US20050272931 Vanilloid receptor ligands and their use in treatments
12/08/2005US20050272803 Phosphodiesterase 4 inhibitors
12/08/2005US20050272798 Analogues of rachelmycin and the duocarmycins that are potent cytotoxins containing a benzodipyrrole or naphthopyrrole ring; anticancer agents
1 ... 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 ... 628